Word,Beta
haematuria,2.80237
and,2.80240
abdominal,2.79502
aortic,2.79502
aneurysm,2.79502
.,2.80240
left,2.80238
loin,2.79469
pain,2.79469
in,2.80240
a,2.80240
patient,2.80240
with,2.80240
associated,2.80240
the,2.80240
radiological,2.80240
finding,2.80240
of,2.80240
poorly,2.80237
or,2.80237
non,2.80237
-,2.80237
functioning,2.80237
kidney,2.80237
are,2.80240
pathognomonic,2.80240
features,2.80240
aorto,2.79605
renal,2.79605
vein,2.79605
fistula,2.78860
,,2.80240
condition,2.80240
which,2.80240
leaks,2.80240
into,2.80240
an,2.80240
anomalous,2.79031
retro,2.79031
acanthosis,2.80238
nigricans,2.80238
is,2.80240
thickened,2.80238
velvety,2.80238
hyperpigmented,2.80239
skin,2.80239
variety,2.80240
endocrine,2.78614
disorders,2.78614
malignancies,2.78614
medications,2.80240
mechanical,2.80240
stability,2.80240
internal,2.80240
fixation,2.80240
fractured,2.80239
phalanges,2.80239
rigidity,2.79469
five,2.80240
techniques,2.80240
tested,2.80240
experimentally,2.80240
compared,2.80240
clinical,2.80240
relevance,2.80240
discussed,2.80240
cell,2.79502
carcinoma,2.79502
concurrent,2.80240
urothelial,2.79502
urinary,2.76877
bladder,2.76877
hodgkin,2.80240
lymphoma,2.80240
we,2.80240
report,2.80240
case,2.80240
71,2.80240
year,2.80240
old,2.80240
male,2.80240
multiple,2.80240
primary,2.80240
involving,2.79031
combined,2.80240
synchronous,0.85994
was,2.80240
admitted,2.80240
to,2.80240
hospital,2.80240
because,2.80240
painless,2.79605
gross,2.79605
hematuria,2.80239
examination,2.80240
revealed,2.80240
tumor,2.79031
right,0.86368
papillary,2.78556
enlarged,2.80240
lymph,2.80240
nodes,2.80240
along,2.79031
aorta,2.79031
inferior,2.79031
vena,2.79031
cava,2.79031
transurethral,2.79646
resection,2.79646
(,2.80240
tur,2.80240
),2.80240
radical,2.80240
nephrectomy,2.80240
retroperitoneal,2.80240
lymphadenectomy,2.80240
were,2.80240
performed,2.80240
pathohistologic,2.80240
evaluation,2.80240
together,2.80240
immunohistochemistry,2.80240
gave,2.80240
final,2.80240
diagnosis,2.80240
rcc,2.79502
b,2.80240
small,2.80240
cll,2.80240
scanning,2.80240
electron,2.80240
microscopy,2.80240
human,2.80240
zonule,2.80240
lens,2.80240
zonula,2.80240
ciliaris,2.80240
present,2.80240
study,2.80240
eight,2.80240
eyeballs,2.80240
specifically,2.80240
prepared,2.80240
for,2.80240
microscopic,2.80240
observation,2.80240
consisted,2.80240
two,2.80240
main,2.80240
layers,2.80240
radial,2.80240
fibres,2.80240
anterior,2.80240
posterior,2.80240
one,2.80240
that,2.80240
inserted,2.80240
on,2.80240
capsules,2.80240
respectively,2.80240
some,2.80240
equator,2.80240
zonular,2.80240
originated,2.80240
at,2.80240
pars,2.80240
plana,2.80240
entered,2.80240
dorsal,2.80240
part,2.80240
ciliary,2.80240
valleys,2.80240
then,2.80240
changed,2.80240
their,2.80240
direction,2.80240
towards,2.80240
face,2.80240
capsule,2.80240
by,2.80240
branched,2.80240
endings,2.80240
1,2.80240
mm,2.80240
behind,2.80240
mainly,2.80240
occasionally,2.80240
after,2.80240
running,2.80240
completely,2.80240
through,2.80240
close,2.80240
contact,2.80240
lateral,2.80240
walls,2.80240
processes,2.80240
they,2.80240
plicata,2.80240
reached,2.80240
insertions,2.80240
achieved,2.80240
webbed,2.80240
diffused,2.80240
2,2.80240
front,2.80240
extraordinary,2.80240
distension,2.80240
capacity,2.80240
demonstrated,2.80240
pulling,2.80240
hydrodissection,2.80240
as,2.80240
consequence,2.80240
stretched,2.80240
up,2.80240
four,2.80240
times,2.80240
original,2.80240
length,2.80240
without,2.80240
breaking,2.80240
disinserting,2.80240
sonographic,2.74905
pseudokidney,2.80237
when,2.80237
interpreting,2.80237
sonograms,2.80237
should,2.80237
be,2.80237
aware,2.80237
possibility,2.80237
mistaking,2.80237
fat,2.74905
scarring,2.74905
fossa,2.74905
normal,2.80237
history,2.80237
prior,2.80237
doubt,2.80237
ultrasound,2.80237
findings,2.80237
confirmed,2.80237
ct,2.80237
scan,2.80237
color,2.79031
pattern,2.79031
reversal,2.79031
visual,2.79031
evoked,2.79031
potential,2.79031
eyes,2.80240
ocular,2.79605
hypertension,2.80238
open,2.80240
angle,2.80240
glaucoma,2.80240
testing,2.80240
99,2.80240
27,2.80240
30,2.80240
use,2.80240
black,2.80240
white,2.80240
red,2.80240
blue,2.80240
checkerboard,2.80240
stimuli,2.80240
p1,2.79031
wave,2.79031
peak,2.79031
time,2.79031
amplitude,2.79031
significantly,2.80240
different,2.80240
from,2.80240
those,2.80240
age,2.80240
similar,2.80240
especially,2.80240
checkerboards,2.80240
p,2.80240
less,2.80240
than,2.80240
0,2.80240
001,2.80240
differences,2.80240
between,2.80240
hypertensive,2.80237
glaucomatous,2.80237
significance,2.80240
difference,2.79031
may,2.80240
serve,2.80240
important,2.80240
parameter,2.80240
early,2.80240
comparison,2.80240
secretory,2.80240
iga,2.80240
igg,2.80240
isotype,2.80240
levels,2.80240
palatal,2.80240
secretions,2.80240
denture,2.79646
stomatitis,2.80239
patients,2.80240
wearers,2.80240
having,2.80240
clinically,2.80240
healthy,2.80240
palates,2.80240
inflammatory,2.78556
affecting,2.80240
mucosa,2.80240
covered,2.80240
aetiology,2.80240
multifactorial,2.80240
poor,2.80238
hygiene,2.80238
constant,2.79031
wearing,2.79031
trauma,2.76877
colonisation,2.80238
candida,2.80238
species,2.80238
inflamed,2.74905
tissues,2.74905
raised,2.79031
albumin,2.79031
isotypes,2.79031
siga,2.79031
would,2.80240
expected,2.80240
major,2.80240
component,2.80240
protective,2.80240
immunological,2.80240
response,2.80240
mucosal,2.80240
injection,2.80240
21,2.80240
22,2.80240
analysed,2.80240
found,2.80240
higher,2.80240
palate,2.80240
unexpectedly,2.80240
<,2.80240
05,2.80240
lower,2.80240
percutaneous,2.80240
support,2.80240
failing,2.74905
heart,2.74905
ventricular,2.80238
rv,2.80238
failure,2.80238
increasingly,2.80240
common,2.80240
problem,2.80240
require,2.80240
contrast,2.80240
severe,2.80240
typically,2.80240
more,2.80240
reversible,2.80240
therefore,2.80240
application,2.80240
shorter,2.80240
term,2.80240
devices,2.80240
potentially,2.80240
attractive,2.80240
current,2.80240
innovations,2.80240
promise,2.80240
greater,2.80240
availability,2.80240
such,2.80240
this,2.80240
article,2.80240
considers,2.80240
available,2.80240
approaches,2.80240
provide,2.80240
hemodynamic,2.80240
treat,2.80240
profound,2.80240
scenarios,2.80240
most,2.80240
beneficial,2.80240
tetralogy,2.79646
fallot,2.79646
levoatrial,2.80238
cardinal,2.80238
rare,2.80240
congenital,2.80238
anomaly,2.80238
systemic,2.80238
veins,2.80238
it,2.80240
frequently,2.80240
side,2.76484
obstructive,2.76484
anomalies,2.76484
innominate,2.79031
absent,2.79031
upper,2.79031
pulmonary,2.79031
connected,2.79031
there,2.80240
no,2.80240
root,2.80240
replacement,2.80240
cardiac,2.77437
dextroversion,2.75515
adult,2.80240
surgery,2.80240
malrotation,0.87234
60,2.80240
lady,2.80240
known,2.80240
presented,2.80240
dyspnoea,2.79031
pre,2.79031
syncopal,2.79031
attacks,2.79031
echocardiographical,2.80240
investigation,2.80240
clockwise,2.79031
rotation,2.79031
its,2.79031
longitudinal,2.79031
axis,2.79031
resulted,2.80240
outflow,2.79031
tract,2.79031
artery,2.79031
being,2.79031
wrapped,2.79031
anteriorly,2.79031
around,2.79031
displacement,2.79031
atrium,2.79031
presence,2.80240
heavily,2.80240
calcified,2.75515
bicuspid,2.77008
valve,2.77008
dilated,0.87234
ascending,0.87234
also,2.80240
venous,2.80240
cannulation,2.80240
established,2.80240
rotating,2.80240
anticlockwise,2.80240
access,2.80240
gained,2.80240
superior,2.80240
oblique,2.80240
aortotomy,2.80240
replaced,2.80240
valved,2.80240
conduit,2.80240
authors,2.80240
',2.80240
knowledge,2.80240
first,2.80240
iatrogenic,2.80238
cyanosis,2.76829
clubbing,2.78556
:,2.80240
25,2.80240
years,2.80240
chronic,2.76960
hypoxia,2.77437
repair,2.80240
atrial,2.80238
septal,2.80238
defect,2.80238
sinus,2.78615
venosus,2.78615
caval,2.80240
type,2.80240
unintentional,2.80240
diversion,2.79031
blood,2.79031
reported,2.80240
long,2.80240
standing,2.80240
anatomical,2.80240
shunting,2.79646
cerebrovascular,2.80238
complications,2.80238
risks,2.80240
depend,2.80240
absence,2.80240
hematological,2.78556
abnormalities,2.78556
degree,2.80240
magnetic,2.80240
resonance,2.80240
imaging,2.80240
clarified,2.80240
etiology,2.80240
unexplained,2.80240
delineated,2.80240
surgical,2.80240
anatomy,2.80240
radioimmunoassay,2.80240
immunoreactive,2.80240
c,2.80240
terminal,2.80240
big,2.80240
endothelin,2.80240
38,2.80240
potent,2.80240
endogenous,2.80240
vaso,2.80240
constrictor,2.80240
derived,2.80240
biosynthetic,2.80240
precursor,2.80240
proteolytic,2.80240
degradation,2.80240
last,2.80240
step,2.80240
cleaves,2.80240
fragment,2.80240
have,2.80240
developed,2.80240
peptide,2.80240
based,2.80240
antiserum,2.80240
recognizing,2.80240
sequence,2.80240
cross,2.80240
reacting,2.80240
intact,2.80240
test,2.80240
plasma,2.80240
samples,2.80240
extracted,2.80240
passage,2.80240
c18,2.80240
silica,2.80240
cartridges,2.80240
desorption,2.80240
methanol,2.80240
/,2.80240
water,2.80240
volume,2.80240
fraction,2.80240
8,2.80240
yields,2.80240
purification,2.80240
concentration,2.80240
procedure,2.80240
about,2.80240
70,2.80240
%,2.80240
15,2.80240
persons,2.80240
concentrations,2.80240
11,2.80240
pmol,2.80240
l,2.80240
10,2.80240
fold,2.80240
reference,2.80240
thus,2.80240
peptides,2.80240
containing,2.80240
but,2.80240
do,2.80240
circulate,2.80240
if,2.80240
sufficiently,2.80240
tight,2.80240
correlation,2.80240
circulating,2.80240
can,2.80240
proven,2.80240
facilitate,2.80240
studies,2.80240
physiological,2.80240
role,2.80240
visualization,2.80240
heterogeneous,2.80240
membrane,2.80240
distribution,2.80240
sphingomyelin,2.80240
cytokinesis,2.80240
polarity,2.80240
sphingolipidosis,2.79502
sm,2.80240
sphingolipid,2.80240
mammalian,2.80240
cells,2.80240
form,2.80240
specific,2.80240
lipid,2.80240
domains,2.80240
cholesterol,2.80240
however,2.80240
methods,2.80240
examine,2.80240
limited,2.80240
model,2.80240
membranes,2.80240
fluorescent,2.80240
protein,2.80240
conjugates,2.80240
binding,2.80240
toxins,2.80240
lysenin,2.80240
lys,2.80240
equinatoxin,2.80240
ii,2.80240
eqtii,2.80240
recognize,2.80240
distributions,2.80240
;,2.80240
exclusively,2.80240
binds,2.80240
clustered,2.80240
whereas,2.80240
preferentially,2.80240
dispersed,2.80240
freeze,2.80240
fracture,2.80240
immunoelectron,2.80240
showed,2.80240
not,2.80240
formed,2.80240
surface,2.80240
glycolipids,2.80240
affect,2.80240
using,2.80240
derivatives,2.80240
sensitive,2.80240
probes,2.80240
exclusive,2.80240
accumulation,2.80240
clusters,2.80240
midbody,2.80240
interestingly,2.80240
apical,2.80240
differentiated,2.80240
epithelial,2.80240
exhibited,2.80240
basolateral,2.80240
acid,2.79031
sphingomyelinase,2.79031
deficient,2.79031
niemann,2.80240
pick,2.80240
these,2.80240
data,2.80240
suggest,2.80240
both,2.80240
content,2.80240
crucial,2.80240
pathophysiological,2.80240
events,2.80240
bringing,2.80240
therapeutic,2.80240
perspective,2.80240
makino,2.80240
abe,2.80240
m,2.80240
murate,2.80240
inaba,2.80240
t,2.80240
yilmaz,2.80240
n,2.80240
hullin,2.80240
matsuda,2.80240
f,2.80240
kishimoto,2.80240
schieber,2.80240
taguchi,2.80240
arai,2.80240
h,2.80240
anderluh,2.80240
g,2.80240
parton,2.80240
r,2.80240
kobayashi,2.80240
improvement,2.80240
eeg,2.80240
signal,2.80240
acquisition,2.80240
electrical,2.80240
aspect,2.80240
state,2.80240
art,2.80240
end,2.80240
aim,2.80240
practical,2.80240
considerations,2.80240
acquiring,2.80240
satisfactory,2.80240
signals,2.80240
electroencephalographic,2.80240
users,2.80240
system,2.80240
designers,2.80240
choosing,2.80240
correct,2.80240
electrode,2.80240
design,2.80240
strategy,2.80240
initial,2.80240
electronic,2.80240
circuitry,2.80240
plays,2.80240
improving,2.80240
s,2.80240
measurement,2.80240
performance,2.80240
considering,2.80240
pitfalls,2.80240
biopotential,2.80240
recording,2.80240
session,2.80240
conditions,2.80240
creates,2.80240
better,2.80240
accuracy,2.80240
electroencephalogram,2.80240
electrodes,2.80240
electronics,2.80240
including,2.80240
filtering,2.80240
amplifying,2.80240
conversion,2.80240
storing,2.80240
environmental,2.80240
paper,2.80240
principles,2.80240
points,2.80240
noise,2.80240
reduction,2.80240
suggestions,2.80240
comparative,2.80240
vitro,2.80240
activity,2.80240
new,2.80240
oral,2.80240
cephalosporin,2.80240
bmy,2.80240
28100,2.80240
broth,2.80240
microdilution,2.80240
method,2.80240
against,2.80240
365,2.80240
strains,2.80240
commonly,2.80240
isolated,2.80240
bacteria,2.80240
determined,2.80240
good,2.80240
streptococci,2.80240
methicillin,2.80240
susceptible,2.80240
staphylococci,2.80240
salmonella,2.80240
spp,2.80240
shigella,2.80240
beta,2.80240
lactamase,2.80240
producing,2.80240
branhamella,2.80240
catarrhalis,2.80240
haemophilus,2.80240
influenzae,2.80240
organisms,2.80240
comparable,2.80240
penicillin,2.80240
ampicillin,2.80240
co,2.80240
trimoxazole,2.80240
erythromycin,2.80240
cefaclor,2.80240
doxycycline,2.80240
amoxicillin,2.80240
potassium,2.80240
clavulanate,2.80240
had,2.80240
moderate,2.80240
arizona,2.80240
hinshawii,2.80240
campylobacter,2.80240
jejuni,2.80240
yersinia,2.80240
enterocolitica,2.80240
reimplantation,2.80238
ectopic,2.80238
ureter,2.80238
duplex,2.80238
separate,2.80238
unit,2.80238
provided,2.80238
alternative,2.80238
ureters,2.80238
whom,2.80238
ureteroureterostomy,2.80238
double,2.80238
might,2.80238
compromised,2.80238
smaller,2.80238
caliber,2.80238
folliculitis,2.79502
follicular,2.79502
mucinosis,2.79502
papular,2.79502
presentation,2.80240
myelomonocytic,2.80240
leukemia,2.80240
leukemias,2.80240
lymphomas,2.80240
indolent,2.80240
surprisingly,2.80240
unusual,2.80240
manners,2.80240
although,2.80240
uncommon,2.80240
lesions,2.75358
eosinophilic,2.78957
been,2.80240
association,2.80240
novel,2.80240
associations,2.80240
acute,2.79031
straight,2.79031
instability,2.79031
knee,2.79031
ligamentous,2.75358
injuries,2.75358
joint,2.75358
represent,2.80238
orthopaedic,2.80238
damage,2.79605
supporting,2.79605
structures,2.79605
relatively,2.80238
occurrence,2.80238
osteosarcoma,2.80240
medial,2.79646
cuniform,2.79646
bone,2.79646
malignancy,2.79502
childhood,2.80240
adolescent,2.80240
related,2.79031
marrow,2.79031
usually,2.80240
occurs,2.80240
bones,2.80240
foot,2.80240
very,2.80240
here,2.80240
i,2.80240
tried,2.80240
cuneiform,2.80238
responding,2.80240
evidence,2.80240
breastfeed,2.80240
baby,2.80240
you,2.80240
sixth,2.80240
public,2.80240
health,2.80240
recommendation,2.80240
reduce,2.80240
risk,2.80240
sudden,2.80238
unexpected,2.80238
death,2.80238
infancy,2.80238
abundant,2.80240
recognises,2.80240
breastfeeding,2.80240
significant,2.80240
short,2.80240
benefits,2.80240
infant,2.80240
mother,2.80240
until,2.80240
recently,2.80240
independent,2.80240
factor,2.80240
reducing,2.80240
remained,2.80240
unclear,2.80240
october,2.80240
2010,2.80240
sids,2.79031
kids,2.80240
australia,2.80240
held,2.80240
consensus,2.80240
forum,2.80240
international,2.80240
researchers,2.80240
key,2.80240
stakeholders,2.80240
review,2.80240
relating,2.80240
safe,2.80240
sleeping,2.80240
recommendations,2.80240
following,2.80240
publication,2.80240
reviews,2.80240
national,2.80240
scientific,2.80240
advisory,2.80240
group,2.80240
has,2.80240
supported,2.80240
decision,2.80240
critical,2.80240
threshold,2.80240
within,2.80240
supportive,2.80240
measure,2.80240
will,2.80240
included,2.80240
2012,2.80240
campaign,2.80240
abusive,2.80237
head,2.77008
infants,2.80240
young,2.80240
children,2.80240
unique,2.80240
contributor,2.80240
developmental,0.86639
disabilities,0.86639
leading,2.80240
cause,2.80240
disability,2.79605
child,2.78556
abuse,2.78556
discusses,2.80240
epidemiology,2.80240
aspects,2.80240
outcomes,2.80240
prevention,2.80240
neglect,2.79469
osteotomy,2.80240
sacrum,2.80240
malignant,2.78614
iliac,2.79502
modified,2.80240
threadwire,2.80240
saw,2.80240
tumors,2.76484
conducted,2.80240
issignificantly,2.80240
wide,2.80240
rapid,2.80240
septic,2.80240
arthritis,2.80240
hip,2.80240
delay,2.80240
treatment,2.80240
lead,2.80240
permanent,2.80240
difficult,2.80240
management,2.80240
reviewed,2.80240
epidemiological,2.80240
median,2.78862
nerve,2.78862
dysfunction,2.78862
practicing,2.80240
dental,2.80240
hygienists,2.80240
purpose,2.80240
assess,2.80240
over,2.80240
changes,2.79031
function,2.79031
20,2.80240
students,2.80240
who,2.80240
university,2.80240
minnesota,2.80240
program,2.80240
1986,2.80240
follow,2.80240
16,2.80240
evaluated,2.80240
postgraduation,2.80240
1990,2.80240
comparisons,2.80240
made,2.80240
evaluations,2.80240
subjects,2.80240
completed,2.80240
graduation,2.80240
1988,2.80240
1989,2.80240
digital,2.80240
vibrometry,2.80240
used,2.80240
evaluate,2.80240
sensibility,2.79031
each,2.80240
periods,2.80240
studied,2.80240
analysis,2.80240
practice,2.80240
mean,2.79031
shift,2.79031
04,2.80240
42,2.80240
measured,2.80240
results,2.80240
indicated,2.80240
observed,2.80240
earlier,2.80240
arrested,2.80240
reasons,2.80240
appeared,2.80240
twofold,2.80240
period,2.80240
work,2.80240
hardening,2.80240
concept,2.80240
neuromuscular,2.80238
tissue,2.78615
hypertrophy,2.75515
adaptation,2.80240
rigors,2.80240
hygienist,2.80240
learned,2.80240
become,2.80240
efficient,2.80240
provision,2.80240
procedures,2.80240
symptoms,2.80240
none,2.80240
diagnosed,2.80240
cts,2.80240
any,2.80240
during,2.80240
since,2.80240
continued,2.80240
necessary,2.80240
determine,2.80240
whether,2.80240
observations,2.80240
noted,2.80240
second,2.80240
temporary,2.80240
slowing,2.80240
development,2.80240
split,2.80240
intrarenal,2.80240
hemodynamics,2.80240
renovascular,2.80238
stenotic,2.80240
contralateral,2.80240
kidneys,2.80240
unilateral,2.74946
rvh,2.80238
estimated,2.80240
gomez,2.80240
formulae,2.80240
ten,2.80240
para,2.79031
amino,2.79031
hippurate,2.79031
inulin,2.79031
clearances,2.79031
ureteral,2.80240
catheterization,2.80240
indexes,2.80240
flow,2.79031
glomerular,2.79031
filtration,2.79031
rates,2.79031
allowing,2.80240
estimation,2.80240
preglomerular,2.79031
arteriolar,2.79031
resistance,2.79031
postglomerular,2.79031
hydrostatic,2.79031
pressure,2.79031
83,2.80240
+,2.80240
12,2.80240
19,2.80240
ml,2.80240
min,2.80240
m2,2.80240
170,2.80240
43,2.80240
4,2.80240
elevated,2.79031
due,2.79031
lesion,2.80237
900,2.80240
500,2.80240
dyns,2.80240
sec,2.80240
cm,2.80240
5,2.80240
while,2.80240
elevation,2.80240
300,2.80240
000,2.80240
high,2.79031
lowered,2.79031
54,2.80240
mmhg,2.80240
3,2.80240
protected,2.80240
138,2.80240
6,2.80240
stenosis,0.86971
increase,2.79031
sufficient,2.80240
making,2.80240
hyperfiltration,2.74946
paget,2.80240
disease,2.80240
complicated,2.80240
hydrocephalus,2.75515
syringomyelia,2.79031
skull,2.80240
basilar,2.75515
impression,2.75515
briefly,2.80240
strategies,2.80240
outlined,2.80240
hemiplegia,2.80240
vegetativa,2.80240
alterna,2.80240
ipsilateral,2.80240
horner,2.80240
syndrome,2.80240
hemihyperhidrosis,2.78957
proximal,2.79031
cerebral,0.86639
occlusion,2.78615
background,2.80240
pca,2.80240
occlusive,2.80240
produces,2.80240
homonymous,2.79031
field,2.79031
defects,2.79031
hemisensory,2.79031
loss,2.79031
neuropsychological,2.79031
deficits,2.79031
conversely,2.80240
combination,2.80240
hemiparesis,0.86971
never,2.80240
before,2.80240
description,2.80240
infarction,0.86971
superficial,2.80240
deep,2.80240
territories,2.80240
picture,2.80240
disclosed,2.80240
infarcts,2.75358
anterolateral,2.80240
midbrain,2.80240
ventroposterolateral,2.80240
thalamic,2.80240
subthalamic,2.80240
area,2.80240
temporo,2.80240
occipital,2.80240
lobes,2.80240
conclusions,2.80240
alternating,2.80239
vegetative,2.79605
supports,2.80240
hypothesis,2.80240
existence,2.80240
uncrossed,2.80240
excitatory,2.80240
crossed,2.80240
inhibitory,2.80240
hypothalamospinal,2.80240
sympathetic,2.80240
pathway,2.80240
erythema,2.78556
multiforme,2.78556
minor,2.78556
vaccination,2.80240
paediatric,2.80240
vaccines,2.80240
cases,2.80240
tetanus,2.79031
diphtheria,2.79031
revaccination,2.79031
acellular,2.74946
pertussis,2.74905
inactivated,2.74946
polio,2.79031
haemophillus,2.77437
vaccine,2.79031
suggesting,2.80240
toxoids,2.79031
precipitating,2.80240
subperiosteal,2.79502
osteoid,2.79502
osteoma,2.79502
distal,2.80240
phalanx,2.80240
thumb,2.80240
osteomas,2.79502
subgrouped,2.80240
cancellous,2.80240
cortical,2.80240
hand,2.80240
location,2.79031
described,2.80240
illustrates,2.80240
radiographic,2.80240
relief,2.80240
factitious,2.77437
coarctation,2.77437
large,2.79502
patent,2.77437
ductus,2.77437
arteriosus,2.77437
gianturco,2.80240
grifka,2.80240
vascular,2.80240
occluder,2.80240
pda,2.77437
hypoplastic,2.74946
isthmus,2.78614
presenting,2.80240
ductal,2.79031
transcatheter,2.80240
gradient,2.79031
resolved,2.80240
thereby,2.80240
eliminating,2.80240
need,2.80240
coexisting,2.80240
central,2.79646
diabetes,2.80240
insipidus,2.80240
psychogenic,2.76484
polydipsia,2.80238
schizophrenic,2.80237
coexisted,2.80240
possible,2.80240
relationship,2.80240
vasopressin,2.80238
release,2.80238
hypothesized,2.80240
lung,2.80238
neoplasm,2.76484
mimicking,2.80240
myocardial,2.79502
involvement,2.80240
pericardium,2.80240
cancer,2.80240
metastases,2.77437
frequent,2.80240
neoplasms,2.79502
metastatic,2.79031
manifestation,2.80240
chest,2.74905
rotaviral,2.80240
gastroenteritis,2.79502
tbilisi,2.80240
electrophoretypes,2.80240
107,2.80240
isolates,2.80240
collected,2.80240
18,2.80240
months,2.80240
seven,2.80240
patterns,2.80240
",2.80240
represented,2.80240
74,2.80240
total,2.80240
number,2.80240
dominated,2.80240
whole,2.80240
seasonal,2.80240
various,2.80240
appearance,2.80240
registered,2.80240
electrophoretype,2.80240
detected,2.80240
hageman,2.80240
xii,2.80240
secific,2.80240
reproducible,2.80240
hf,2.80240
factory,2.80240
purified,2.80240
monospecific,2.80240
rabbit,2.80240
antibody,2.80240
precise,2.80240
measurements,2.80240
antigen,2.80240
low,2.80240
pooled,2.80240
=,2.80240
82,2.80240
existed,2.80240
titers,2.80240
clot,2.80240
promoting,2.80240
assays,2.80240
radioimmunoassays,2.80240
among,2.80240
adults,2.80240
confirming,2.80240
trait,2.80237
other,2.80240
plasmas,2.80240
individuals,2.80240
fletcher,2.76877
fitzgerald,2.76877
contained,2.80240
amounts,2.79031
reduced,2.79031
disseminated,2.76877
intravascular,2.76877
coagulation,2.76877
advanced,2.80240
liver,2.74905
cirrhosis,0.87234
under,2.79031
warfarin,2.79031
assay,2.80240
primates,2.80240
detectable,2.80240
nonprimate,2.80240
avian,2.80240
progressive,2.78956
facial,2.77332
hemiatrophy,2.77332
epileptic,2.79469
seizures,2.76484
intractable,2.79646
complex,2.80239
partial,2.80238
female,2.80240
intracranial,2.80240
computed,2.80240
tomography,2.80240
frontal,2.74905
paramedian,2.74905
band,2.74905
like,2.74905
depression,2.74905
gradually,2.80240
thereafter,2.80240
parry,2.80240
romberg,2.80240
parenchymal,2.80240
calcifications,2.80240
density,2.80238
areas,2.80238
matter,2.80238
frontoparietal,2.80238
neurologic,2.80240
could,2.80240
precede,2.80240
succeeding,2.80240
neurocutaneous,2.79031
remote,2.79031
unpolluted,2.79031
rural,2.79031
south,2.79031
africa,2.79031
14,2.79031
olds,2.79031
wupperthal,2.79031
north,2.79031
western,2.79031
cape,2.79031
province,2.79031
graphite,2.79031
furnace,2.79031
atomic,2.79031
absorption,2.79031
spectrometry,2.79031
analyse,2.79031
level,2.79031
micrograms,2.79031
dl,2.79031
value,2.79031
considered,2.79031
representative,2.79031
natural,2.79031
africans,2.79031
o,2.80240
femoral,2.80240
distractor,2.80240
ankle,2.80240
arthroscopy,2.80240
well,2.80240
technique,2.80240
pins,2.80240
tibia,2.80240
calcaneum,2.80240
able,2.80240
distraction,2.80240
easy,2.80240
operative,2.80240
manipulation,2.80240
obtained,2.80240
commercially,2.80240
distractors,2.80240
broad,2.79031
spectral,2.79031
parameters,2.79031
correlated,2.79031
iq,2.79031
wais,2.79031
all,2.79031
subscales,2.79031
40,2.79031
handed,2.79031
volunteers,2.79031
ranging,2.79031
eegs,2.79031
recorded,2.79031
derivations,2.79031
rest,2.79031
opened,2.79031
reveal,2.79031
positive,2.79031
negative,2.79031
correlations,2.79031
participation,2.79031
bands,2.79031
frequency,2.79031
show,2.79031
narrow,2.79031
range,2.79031
relations,2.79031
highlight,2.79031
psychological,2.79031
tests,2.79031
homogeneous,2.79031
abilities,2.79031
finer,2.79031
clearly,2.79031
explainable,2.79031
demonstrate,2.79031
recordings,2.79031
reflect,2.79031
intellectual,2.79031
stimulus,2.77008
postanoxic,2.80238
myoclonus,2.80238
discuss,2.80240
pathophysiology,2.80240
man,2.80240
sustained,2.80240
cardiorespiratory,2.76484
arrest,2.76484
lasted,2.80240
minutes,2.80240
unresponsive,2.80240
hours,2.80240
stimulation,2.80240
trigeminal,2.80240
innervated,2.80240
periorbital,2.80240
bursts,2.79031
spike,2.79031
generalized,2.79469
myoclonic,2.75515
jerks,2.75515
types,2.80240
did,2.80240
elicit,2.80240
32,2.80240
later,2.80240
nonreactive,2.79031
alpha,2.79031
coma,2.74905
died,2.80240
7,2.80240
days,2.80240
regularity,2.80240
suggests,2.80240
resting,2.80240
electrocerebral,2.79031
silence,2.79031
result,2.80240
suppression,2.80240
disinhibition,2.80240
brainstem,2.78615
generated,2.78615
entity,2.80240
audiology,2.80240
auditory,2.80240
processing,2.80240
speech,2.80240
recognition,2.80240
disorder,2.79502
[,2.74946
apd,2.79502
],2.79502
highly,2.80240
controversial,2.80240
controversy,2.80240
fueled,2.80240
ambiguous,2.80240
descriptions,2.80240
american,2.80240
language,2.80240
hearing,2.80240
academy,2.80240
sources,2.80240
say,2.80240
questionable,2.80240
define,2.80240
nature,2.80240
order,2.80240
intervention,2.80240
nosography,2.80240
systematic,2.80240
diseases,2.79031
physicians,2.80240
thomas,2.80240
sydenham,2.80240
otto,2.80240
guttentag,2.80240
criteria,2.80240
framework,2.80240
conceptualization,2.80240
haemostatic,2.75358
hepatosplenic,2.80240
schistosomiasis,2.80240
mansoni,2.79605
immuno,2.80238
regulatory,2.80238
endemic,2.80240
countries,2.80240
bleeding,2.79031
serious,2.80240
often,2.80240
life,2.80240
threatening,2.80240
prone,2.80240
develop,2.80240
linked,2.80240
ruptured,2.79605
esophageal,2.78553
varices,2.78553
deficit,2.79031
pronounced,2.80240
advancement,2.80240
maximal,2.80240
experience,2.80240
haematomesis,2.80237
evidences,2.80240
enhanced,2.79031
generation,2.79031
thrombin,2.79031
plasmin,2.79031
indicate,2.80240
grade,2.80240
dic,2.80239
principal,2.80240
demonstration,2.80240
procoagulant,2.80240
expression,2.80240
peripheral,2.80240
monocytes,2.80240
livers,2.80240
spleens,2.80240
intestines,2.80240
infected,2.79031
mice,2.80240
implication,2.80240
causation,2.80240
infections,2.80238
moreover,2.80240
indicates,2.80240
immune,2.80240
mechanisms,2.80240
localized,2.80240
seems,2.80240
likely,2.80240
responses,2.79031
schistosomes,2.79031
play,2.80240
pathogenic,2.80240
squamous,2.79605
pleura,2.80238
few,2.80240
reports,2.80240
tumours,2.80238
mesothelioma,2.80240
epidermoid,2.80240
occur,2.80240
connection,2.80240
persistent,2.80240
empyema,2.74905
drained,2.80240
pleurocutaneous,0.86971
extrapleural,2.78556
pneumothorax,2.78556
far,2.80240
somatosensory,2.80240
potentials,2.80240
tibial,2.80240
scalp,2.80240
sep,2.80240
three,2.80240
peaks,2.80240
p17,2.80240
p24,2.80240
p31,2.80240
additional,2.80240
inconsistent,2.80240
components,2.80240
p11,2.80240
p21,2.80240
p27,2.80240
presumable,2.80240
generator,2.80240
popliteal,2.80240
entry,2.80240
sacral,2.80240
plexus,2.80240
cauda,2.80240
equina,2.80240
conus,2.80240
medullaris,2.80240
rostral,2.80240
spinal,2.80240
cord,2.80240
lymphogranuloma,2.80240
venereum,2.80240
tonsil,2.80238
tonsillar,2.80238
similarities,2.80240
tonsils,2.80240
cervical,2.80240
importance,2.80240
histological,2.80240
abnormal,2.77437
reiterated,2.80240
68ga,2.80237
prostate,2.80237
treated,2.80240
stage,2.78614
iiib,2.78614
referred,2.80240
ga,2.79031
psma,2.79031
pet,2.80240
staging,2.80240
addition,2.80240
uptake,2.79031
increased,2.79031
enlarging,2.80238
lobe,2.76877
mass,2.76877
diffusely,2.80240
thyroid,2.80240
gland,2.80240
bilateral,2.80238
supraclavicular,2.80240
fine,2.80240
needle,2.80240
aspiration,2.80240
biopsy,2.80240
node,2.80240
adenocarcinoma,2.79605
interferon,2.80240
recent,2.80240
demonstrating,2.80240
therapy,2.80240
six,2.80240
myeloid,2.80240
leukaemia,2.80240
essential,2.79646
thrombocythemia,2.79469
polycythemia,2.80240
rubra,2.79605
vera,2.79605
myelomatosis,2.80240
hairy,2.80240
screen,2.80240
severity,2.80240
mild,2.79469
traumatic,2.79469
brain,2.79469
injury,2.79469
investigated,2.80240
sensitivity,2.80240
information,2.80240
recall,2.80240
orientation,2.80240
tasks,2.80240
mtbi,2.79469
fifty,2.80240
85,2.80240
57,2.80240
28,2.80240
controls,2.80240
24,2.80240
hr,2.80240
department,2.80240
emergency,2.80240
medicine,2.80240
answered,2.79031
fewer,2.79031
questions,2.79031
recalled,2.79031
words,2.79031
delayed,2.80237
judged,2.79031
sentences,2.79031
correctly,2.79031
immediate,2.79031
memory,2.79031
learning,2.79031
previous,2.80240
perform,2.80240
speed,2.80240
word,2.80240
effects,2.80240
gamma,2.80240
globin,2.80240
promoter,2.80240
base,2.80240
pair,2.80240
deletion,2.80240
mutant,2.80240
shows,2.80240
polymorphic,2.80240
throughout,2.80240
gene,2.80240
fetal,2.80240
genes,2.80240
australian,2.80240
kindred,2.80240
nondeletional,2.79502
hereditary,2.80240
persistence,2.80240
hemoglobin,2.80240
hpfh,2.80240
cloned,2.80240
sequenced,2.80240
198,2.79502
mutation,2.79502
british,2.79469
upstream,2.80240
allele,2.80240
identified,2.80240
222,2.80240
225,2.80240
bp,2.80240
cap,2.80240
site,2.80240
variations,2.80240
ana,2.80240
transition,2.80240
exon,2.80240
402,2.80240
relative,2.80240
hindiii,2.80240
polymorphism,2.80240
intron,2.80240
untranslated,2.80240
region,2.80240
tcac,2.80240
place,2.80240
ctct,2.80240
creating,2.80240
saci,2.80240
previously,2.80240
linkage,2.80240
noteworthy,2.80240
simultaneous,2.80240
mutants,2.80240
same,2.80240
despite,2.80240
resulting,2.80240
phenotype,2.80240
k562,2.80240
transient,2.80240
statistically,2.80240
control,2.80240
vivo,2.80240
identification,2.80240
enzymatically,2.80240
normalized,2.80240
shrna,2.80240
library,2.80240
massive,2.80240
parallel,2.80240
sequencing,2.80240
general,2.80240
approximately,2.80240
150,2.80240
shrnas,2.80240
per,2.80240
redundance,2.80240
cdna,2.80240
constructed,2.80240
inducible,2.80240
lentiviral,2.80240
vector,2.80240
enabling,2.80240
propagation,2.80240
growth,2.80240
inhibiting,2.80240
controlled,2.80240
rnai,2.80240
activities,2.80240
101,2.80240
clones,2.80240
representing,2.80240
100,2.80240
201,2.80240
firefly,2.80240
luciferase,2.80240
structure,2.80240
datasets,2.80240
yielded,2.80240
set,2.80240
structural,2.80240
efficacy,2.80240
increasing,2.80240
frequencies,2.80240
active,2.80240
random,2.80240
sampling,2.80240
select,2.80240
inhibit,2.80240
breast,2.79605
targeting,2.80240
oncogenes,2.80240
targeted,2.80240
selected,2.80240
enriched,2.80240
pathways,2.80240
9,2.80240
cancers,2.79502
cycle,2.80240
progression,2.80240
apoptosis,2.80240
hundred,2.80240
nineteen,2.80240
selection,2.80240
drug,2.80240
targets,2.80240
interfering,2.80240
rnas,2.80240
inhibited,2.80240
validating,2.80240
efficiency,2.80240
throughput,2.80240
target,2.80240
giant,2.74946
tuberculomata,2.80238
misdiagnosed,2.80240
secondary,2.80240
describe,2.80240
attenuation,2.74946
rim,2.80240
enhancement,2.80240
calcific,0.86971
enhance,2.80240
hypoattenuation,2.79031
recovered,2.80240
antituberculous,2.80240
chemotherapy,2.80240
perinatal,2.76484
arterial,2.80238
placental,2.79469
chorioangioma,2.79469
chorioangiomas,2.76829
benign,2.78615
several,2.80240
obstetric,2.79031
premature,2.80237
labor,2.80237
abruption,2.78860
polyhydramnios,2.78860
hydrops,2.78860
restriction,2.79031
hepatosplenomegaly,2.78860
cardiomegaly,2.77437
congestive,2.74946
neonatal,2.80240
fetalis,2.78615
microangiopathic,2.80238
hemolytic,2.80238
anemia,2.80238
thrombocytopenia,2.79031
remains,2.80240
majority,2.80240
investigators,2.80240
setting,2.80240
stroke,2.79502
birth,0.86846
asphyxia,2.77437
preeclampsia,2.78612
chorioamnionitis,2.78860
infection,2.75358
genetic,2.75515
thrombophilias,2.77436
psychophysiological,2.79031
reactions,2.79031
qigong,2.80240
traditional,2.80240
chinese,2.80240
meditation,2.80240
indian,2.80240
yoga,2.80240
japanese,2.80240
zen,2.80240
category,2.80240
psychotherapy,2.80240
series,2.80240
course,2.80240
training,2.80240
inappropriate,2.80240
physical,2.80238
mental,2.80238
disturbances,2.80238
include,2.80240
emg,2.79031
respiratory,2.79031
movement,2.79031
rate,2.79031
temperature,2.79031
finger,2.79031
tip,2.79031
stomach,2.79031
intestine,2.79031
metabolism,2.79031
immunity,2.79031
systems,2.80240
motor,2.79502
phenomena,2.79502
perceptual,2.79502
experienced,2.80240
warmness,2.79031
chilliness,2.80239
itching,2.80239
sensation,2.80239
numbness,2.79031
soreness,2.77437
bloatedness,2.80240
relaxation,2.79031
tenseness,2.79646
floating,2.80237
dropping,2.80237
enlargement,2.80237
constriction,2.80237
body,2.80237
image,2.80237
rising,2.80237
sky,2.80237
falling,2.80237
off,2.80237
upside,2.80237
down,2.80237
playing,2.79031
swing,2.79031
respiration,2.79031
circulation,2.79031
intrinsic,2.79031
qi,2.79031
electric,2.79031
shock,2.79031
formication,2.80237
exercise,2.80240
dreamland,2.74946
illusions,2.74946
unreality,2.80237
pseudohallucination,2.78860
vanished,2.80240
terminated,2.80240
deviation,2.80238
diagnostic,2.80240
now,2.80240
widely,2.80240
china,2.80240
antiproliferative,2.80240
homogenates,2.80240
candidate,2.80240
probiotic,2.80240
unheated,2.80240
heat,2.80240
separately,2.80240
lactobacillus,2.80240
rhamnosus,2.80240
gg,2.80240
bifidobacterium,2.80240
lactis,2.80240
acidophilus,2.80240
delbrueckii,2.80240
subsp,2.80240
bulgaricus,2.80240
streptococcus,2.80240
thermophilus,2.80240
phytohemagglutinin,2.80240
induced,2.80240
proliferation,2.80240
mononuclear,2.80240
homogenate,2.80240
assessing,2.80240
thymidine,2.80240
incorporation,2.80240
cultures,2.80240
suppressed,2.80240
enzymatic,2.80240
heating,2.80240
repeated,2.80240
cytoplasmic,2.80240
wall,2.80240
extracts,2.80240
extract,2.80240
suppressive,2.80240
possess,2.80240
stable,2.80240
generate,2.80240
microbiologically,2.80240
nonviable,2.80240
yet,2.80240
immunologically,2.80240
food,2.80240
products,2.80240
easier,2.80240
store,2.80240
longer,2.80240
shelf,2.80240
focal,0.86639
neurological,2.77437
sarcoidosis,2.79502
presents,2.80240
only,2.80240
infrequently,2.80240
recurrent,2.80239
rarer,2.80240
still,2.80240
describes,2.80240
episodic,2.79469
fluent,2.79469
dysphasia,2.77437
abrupt,2.79031
onset,2.79031
occurring,2.80240
seizure,2.78614
macroscopic,2.79031
granulomatous,2.79031
collection,2.79031
neurosarcoidosis,2.79502
mimic,2.80240
classic,2.80240
ischaemic,2.77436
questionnaire,2.80238
transplant,2.80238
quality,2.80238
recipients,2.80238
list,2.80238
items,2.80238
created,2.80238
50,2.80238
rated,2.80238
item,2.80238
judgment,2.80238
create,2.80238
consists,2.80238
dimensions,2.80238
fatigue,2.80238
uncertainty,2.80238
fear,2.80238
emotions,2.80238
dimension,2.80238
scored,2.80238
point,2.80238
likert,2.80238
scale,2.80238
reproducibility,2.80238
administered,2.80238
intraclass,2.80238
coefficients,2.80238
91,2.80238
scores,2.80238
except,2.80238
improved,2.80238
transplantation,2.80238
pretransplantation,2.80238
graft,2.80238
creatinine,2.80238
250,2.80238
mmol,2.80238
grafts,2.80238
administer,2.80238
valid,2.80238
responsive,2.80238
change,2.80238
carbon,2.80240
monoxide,2.80240
suppresses,2.80240
tlr4,2.80240
via,2.80240
differentiation,2.80240
betatc3,2.80240
islet,2.80240
allografts,2.80240
donor,2.80240
exposed,2.80240
rejection,2.80240
trafficking,2.80240
activation,2.80240
islets,2.80240
molecular,2.80240
how,2.80240
remain,2.80240
focus,2.80240
insulinoma,2.78615
line,2.80240
stably,2.80240
transfected,2.80240
pcdna3,2.80240
yfp,2.80240
pdsred,2.80240
monomer,2.80240
golgi,2.80240
plasmids,2.80240
identify,2.80240
subcellular,2.80240
lps,2.80240
confocal,2.80240
immunofluorescence,2.80240
resides,2.80240
apparatus,2.80240
quiescent,2.80240
led,2.80240
interaction,2.80240
md,2.80240
immunoprecipitation,2.80240
depleting,2.80240
rna,2.80240
blocking,2.80240
glycosylation,2.80240
tunicamycin,2.80240
blocked,2.80240
exposing,2.80240
parts,2.71828
million,2.71828
conclusion,2.71828
required,2.71828
consequent,2.71828
transvesical,2.71828
endoscopic,2.71828
placement,2.71828
sutures,2.71828
urethral,2.71828
strictures,2.71828
reapproximation,2.71828
urethra,2.71828
across,2.71828
excised,2.71828
scar,2.71828
requires,2.71828
perineum,2.71828
external,2.71828
sphincter,2.71828
prostatic,2.71828
itself,2.71828
problematic,2.71828
suprapubic,2.71828
cystostomy,2.71828
eliminates,2.71828
usual,2.71828
difficulties,2.71828
volatile,2.71828
flavor,2.71828
rice,2.71828
cakes,2.71828
volatiles,2.71828
laboratory,2.71828
dynamic,2.71828
headspace,2.71828
isolation,2.71828
tenax,2.71828
trapping,2.71828
carried,2.71828
out,2.71828
capillary,2.71828
gc,2.71828
ms,2.71828
compounds,2.71828
hydroxy,2.71828
propanone,2.71828
furfuryl,2.71828
alcohol,2.71828
dimethylpyrazine,2.71828
methylpyrazine,2.71828
pyrazine,2.71828
hexanal,2.71828
furfural,2.71828
pentanol,2.71828
butanone,2.71828
acetoin,2.71828
ethyl,2.71828
ideally,2.71828
applicable,2.71828
dry,2.71828
product,2.71828
ratios,2.71828
probability,2.71828
contributing,2.71828
aroma,2.71828
methylbutanal,2.71828
dimethyl,2.71828
trisulfide,2.71828
vinylguaiacol,2.71828
e,2.71828
decadienal,2.71828
acetyl,2.71828
pyrroline,2.71828
octen,2.71828
ol,2.71828
